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Abstract 
Background: Increasing evidence suggests that methicillin-resistant Staphylococcus aureus (MRSA) infections 
are becoming more prevalent throughout the human immunodeficiency virus (HIV) infected community. 
However, there is scarcity of data about the prevalence of MRSA among HIV positive pediatric patients in the 
study area. 
Objectives: To determine the prevalence and types of MRSA among S. aureus isolates of HIV positive pediatric 
patients in the Amhara National Regional State, Northwest Ethiopia. 
Methods: Pediatric patients who attended the clinic from December 2013 to April 2014 were included in the 
study. Genotype MRSA VER 3.0 was used for characterization of S. aureus isolates. This detected methicillin-
resistance-mediating mecA and mecC genes and the bicomponent cytotoxic virulence factor Panton–Valentine 
leukocidin (PVL). Data were analyzed using SPSS version 20.  
Results: Among 126 S. aureus isolates, 37.3% and 11.9% were mecA and Panton–Valentine leukocidin gene 
positive, respectively. Patients of FHRH (P = 0.04) and DRH (P = 0.02) have statistical significance for mecA 
gene.  Panton–Valentine leukocidin gene positive strains were about 97% less likelihood to be mecA gene positive 
(P = 0.001). 
Conclusion: A high prevalence of pathogenic MRSA strains among HIV positive pediatric patients was observed. 
Most of the MRSA types were hospital acquired. Hence, strict hygienic approaches by healthcare workers in 
hospitals should be implemented. In addition, screening and treatment of MRSA for HIV positive pediatric 
patients is recommended. [Ethiop. J. Health Dev.  2018;32(3):00-000] 
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Introduction  
The increasing frequency of antimicrobial resistance 
among infectious organisms is of great concern to both 
the general public and health service providers (1). The 
acquisitions of the staphylococcal cassette chromosome 
harbor the mecA gene. Expression of mecA gene yields 
a penicillin-binding protein (PBP2a) that reduces the 
bacterium’s susceptibility to beta-lactam drugs. It is 
interesting to note that the cassette that harbors the 
mecA gene is also capable of ‘trapping’ drug-resistant 
plasmids and transposons, and thereby increasing the 
drug resistance of S. aureus (2). 
 
Methicillin-resistant Staphylococcus aureus (MRSA) is 
contagious and can cause life-threatening infection. 
Although MRSA was originally associated with health 
care-acquired infections, it also began to be recognized 
as an important cause of community-onset infections in 
the late 1990s (3-5). Community-acquired MRSA (CA-
MRSA) isolates carry much smaller staphylococcal 
cassettes (SCCmec types IV, V or VII), (6,7) have 
different lineages (8-12) and carry the Panton–
Valentine leukocidin (PVL) gene (8). Innate immunity 
represents the main host defense against S. aureus, 
with neutrophils being the primary cellular defense of 
the innate immune response (13,14). In people infected 
with HIV, S. aureus infections account for significant 
morbidity (15-17). A higher isolation rate of MRSA 
has been reported from most African countries, 
including Nigeria (29.6%), Kenya (27.7%), Cameroon 
(21.3%), Côte d’Ivoire (16.8%) and Morocco (14.4%) 
(18). 
 
MRSA is an important cause of infections and HIV-
infected individuals are frequently susceptible to this 
pathogen. HIV positive pediatric patients are also the 
most vulnerable group of people for different types of 
infectious disease. In Ethiopia, particularly in Amhara 
Region, there is a paucity of data about the prevalence 
of MRSA among HIV positive pediatric patients. 
Moreover, we haven’t seen any data on genotype level 
to assess the real burden of MRSA on this population 
group. Hence, this study was designed to determine the 
prevalence and type of MRSA with genotype method 
among S. aureus isolates of HIV positive pediatric 
patients in Northwest Ethiopia. The findings of this 
research, especially the identification of types of 
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MRSA, will have great public health implications for 
the prevention and control of MRSA in Ethiopia. 
 
Materials and methods 
Study design and period:  An institutional-based cross-
sectional study was conducted from December 2013 to 
April 2014. Study participants were recruited from the 
pediatric HIV clinics at Felege Hiwot Referral Hospital 
(FHRH), Debre-Tabor Hospital (DTH) and Dessie 
Referral Hospital (DRH), in the Amhara National 
Regional State. Participants living with HIV, <18 years 
of age, receiving medical care at the aforementioned 
health facilities, were included in the study. Patients 
who were on antibiotic treatment for any bacterial 
infection during the time of data collection were 
excluded from the study. 
  
Variables:  Sex, age and residency were used as the 
demographic variables. Medical history (WHO clinical 
categories, immunological markers and type of ARV 
drugs used during therapy, and so on), were also used 
as clinical variables, which were taken from the 
medical records of clients at the aforementioned 
hospitals. The MRSA mediating mecA and mecC 
genes and the bicomponent cytotoxic virulence factor 
PVL genes were also considered as variables. 
 
Data collection:  A structured questionnaire was used 
to collect data on patients’ demographic characteristics. 
Moreover, patients’ medical records were used to 
assess the clinical history of the participants. Genotypic 
data on S. aureus colonization and drug susceptibility 
profiles of the isolates were also collected from the 
genotype MRSA test. 
 
Laboratory procedures:  From each participant, 
specimens for S. aureus isolation were collected from 
the anterior nares, the back of the wrist and the 
perineum using sterile swabs. Swabs were plated on 
mannitol salt agar and blood agar. Culture plates were 
incubated at 35oC for 24 to 48 hours aerobically. The 
202 culture positive patients were prepared for further 
molecular detection of S. aureus and MRSA. 
 
Detection of S. aureus and MRSA by Genotype 
MRSA VER 3.0:  The Genotype MRSA VER 3.0 is a 
qualitative in vitro test for characterization of S. aureus 
and S. epidermidis strains. At the same time, the 
methicillin-resistance-mediating mecA and mecC 
genes, as well as the bicomponent cytotoxic virulence 
factor PVL, were detected. The Genotype MRSA test 
is based on the DNA •STRIP technology. 
  
DNA extraction, amplification and hybridization:  
Bacteria freshly grown on culture plates were used as 
starting material for DNA extraction. The standardized 
quick protocols were used for DNA extraction from 
cultured material. After spin down for 5 minutes at 
maximum speed, 5μl of the supernatant was collected 
for polymerase chain reaction (PCR). All reagents 
needed for amplification, such as polymerase and 
primers, were included in the amplification mixes. The 
thermal cycler was installed based on the Hain 
Lifescience Protocol ‘MRSA HOT’. We performed 
hybridization on ‘overview equipment programs’, 
which are available on www.hain-lifescience.com. 
 
Data quality assurance:  Pre-trained antiretroviral 
treatment (ART) nurses collected samples and 
demographic and clinical data. Culture was done by 
experienced bench microbiologists. Here, we were 
adhering strictly to the established procedures of the 
test, according to the ‘Guidelines for the laboratory 
diagnosis and susceptibility testing of methicillin-
resistant Staphylococcus aureus’ (19). Moreover, data 
were double entered and analyzed in consultation with 
a statistician. 
 
Definitions:  Participants were classified as ‘MRSA 
colonized’ if mecA gene was detected from either of 
the nares, premium or the skin. Participants colonized 
with both methicillin-susceptible S. aureus (MSSA) 
and MRSA (regardless of site) were classified as 
‘MRSA colonized’. 
 
Statistical methods:  Data were entered and analyzed 
using SPSS statistical package, version 20. Binary 
logistic regression analysis was carried out to 
determine the association between explanatory 
variables and the outcome variable. Odds ratios (ORs) 
and their 95% confidence intervals (CIs) were 
calculated, and the results were considered statistically 
significant at p < 0.05. 
 
Results  
Socio-demographic characteristics:  In this study, 400 
HIV-infected pediatric patients were included. Of 
those, 202 were phenotypically isolated as culture 
positive for S. aureus and their details have been 
discussed elsewhere (20). However, among 202 culture 
positive samples, only 126 were eligible and confirmed 
with genotype MRSA. Most of the participants (78.6%) 
were urban dwellers and the majorities were from 
Felege Hiwot Referral Hospital (60.3%). Females 
accounted for 54% of the cases (Male: Female ratio = 
1.17:1) with the mean age of 10.00 (SD ±3.34). The 
















MRSA, pediatrics, HIV, Ethiopia     3 
 
Ethiop. J. Health Dev.  2018;32(3) 
Table 1: Demography and general description of variables among HIV positive pediatric  
patients who were isolated as S. aureus with genotype MRSA in Northwest Ethiopia 
  Variables Frequency no. (%) 
Study sites   
FHRH 76 (60.3) 
DRH 43 (34.1) 
DTH 7 (5.6) 
Gender   
Female 68 (54.0) 
Male 58 (46.0) 
Residence   
Urban 99 (78.6) 
Rural 27 (21.4) 
Hospitalization in the last one year  
Yes 5 (4.0) 
No 121 (96.0) 
Skin lesion   
Yes 13 (10.3) 
No 113 (89.7) 
Taking ART   
Yes 102 (81.0) 
No 24 (19.0) 
Age   
<5 11 (8.7) 
≥5 115 (91.3) 
Last CD4 count  
≤403 35 (27.8) 
404-638 31 (24.6) 
639-918 28 (22.2) 
>918 32 (25.4) 
mecA gene   
Positive 47 (37.3) 
Negative 79 (62.7) 
mecC gene  
Positive 2 (1.6) 
Negative 124 (98.4) 
PVL gene  
Positive 15 (11.9) 
Negative 111 (88.1) 
Key: FHRH = Felege Hiwot Referral Hospital, DRH = Dessie Referral Hospital,  
DTH = Debre-Tabor Hospital
 
Prevalence and associated risk factors of MRSA:  
Among S. aureus positive patients, 47 (37.3%) were 
mecA gene positive, as computed from counts of 
MRSA at any one of the specimens collected from each 
patient. The majority of MRSA cases were identified 
among those who had a history of hospitalization in the 
last 12 months (80.0%). Moreover, patients with the 
last CD4 count less than or equal to 403 were the 
highest group for MRSA colonization (54.3%). The 
highest proportion of MRSA species were identified 
from the perineum (59.5%), followed by skin swab 
(43.6%) (Figure 1). From the chi- squared test, the 
variables such as study sites (2 = 8.17), history of 
hospitalization in the last one year (2 = 4.05), last 
CD4 count (2 = 6.12) and PVL gene expression (2 = 
22.84) showed an association to mecA gene (Table 2). 
However, with the logistic regression model, being 
patients of FHRH (AOR = 19.6, 95% CI: 2.20-175.49, 
P value = 0.04) and DRH (AOR = 13.6, 95% CI: 1.46-
126.15), P value = 0.02) had statistical significance for 
the positivity of mecA gene. Furthermore, PVL gene 
positive strains were about 97% less likelihood to be 
mecA gene positive (AOR = 0.03, 95% CI: 0.003-0.19, 
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Table 2: The chi-squared values of variables with mecA gene among S. aureus isolates of HIV positive 
pediatric patients in Northwest Ethiopia 
Variables  mecA gene Chi square  
Positive Negative 
Study sites    2 = 8.17 
Df = 2 
 
FHRH 24 (31.6) 52 (68.4) 
DRH 17 (39.5) 26 (60.5) 










2 = 0.26 
Df = 1 
 
Residence    2 = 0.17 
Df = 1 Urban 36 (36.4) 63 (63.6) 
Rural 11 (40.7) 16 (59.3) 
Hospitalization in the last one 
year 
  2 = 4.05 
Df = 1 
Yes   4 (80.0)   1 (20.0) 
No 43 (35.5) 78 (64.5) 
Skin lesion    2 = 0.26 
Df = 1 Yes   4 (30.8)   9 (69.2) 
No 43 (38.1) 70 (61.9) 
Taking ART   2 = 0.00 
Df = 1 Yes 38 (37.3) 64 (62.7) 
No   9 (37.5) 15 (62.5) 
Age    2 = 0.34 
Df = 1 <5   5 (45.5)   6 (54.5) 
≥5 42 (36.5) 73 (63.5) 
Last CD4 count   2 = 6.12 
Df = 3 
 
≤403 19 (54.3) 16 (45.7) 
404-638 10 (32.3) 21 (67.7) 
639-918   9 (32.1) 19 (67.9) 
>918   9 (28.1) 23 (71.9) 
mecC gene   2 = 0.14 
Df = 1 Positive   1 (50.0)   1 (50.0) 
Negative 46 (37.1) 78 (62.9) 
PVL gene   2 = 22.86 
Df = 1 Positive 14 (93.3)   1 (6.7) 
Negative 33 (29.7) 78 (70.3) 
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Table 3: Association of variables with mecA gene among S. aureus isolates of HIV positive pediatric 
patients in Northwest Ethiopia 
Variables mecA gene  COR (95%CI),PV AOR (95% CI),PV 
Positive  Negative  
Study sites      
FHRH 24 (31.6) 52 (68.4) 13.0(1.48-114.03),0.02 19.6(2.20-175.49),0.08 
DRH 17 (39.5) 26 (60.5) 9.1(1.01-83.10),0.05 13.6(1.46-126.15),0.02 
















Residence      
Urban 36 (36.4) 63 (63.6) 1.2(0.50-2.87),0.67 1.45(0.53-3.94),0.46 
Rural 11 (40.7) 16 (59.3) 1 1 
Hospitalization in the 
last one year 
    
Yes   4 (80.0)   1 (20.0) 0.14(0.01-1.27),0.08 0.41(0.02-6.36),0.53 
No 43 (35.5) 78 (64.5) 1 1 
Skin lesion      
Yes   4 (30.8)   9 (69.2) 1.38(0.40-4.76),0.61 2.40(0.38-14.95),0.34 
No 43 (38.1) 70 (61.9) 1 1 
Taking ART     
Yes 38 (37.3) 64 (62.7) 1.01(0.40-2.53),0.98 1.22(0.38-3.91),0.72 
No   9 (37.5) 15 (62.5) 1 1 
Age      
<5   5 (45.5)   6 (54.5) 1.44(0.42-5.03),0.56 0.55(0.13-2.36),0.42 
≥5 42 (36.5) 73 (63.5) 1 1 
Last CD4 count     
≤403 19 (54.3) 16 (45.7) 0.33(0.12-0.91),0.03 0.49(0.14-1.72),0.26 
404-638 10 (32.3) 21 (67.7) 0.82(0.28-2.41),0.72 1.05(0.28-3.87),0.94 
639-918   9 (32.1) 19 (67.9) 0.82(0.27-2.49),0.73 0.81(0.23-2.75),0.73 
>918   9 (28.1) 23 (71.9) 1 1 
mecC gene     
Positive   1 (50.0)   1 (50.0) 0.60(0.03-9.65),0.71 1.69(0.02-105.72),0.80 
Negative 46 (37.1) 78 (62.9) 1 1 
PVL gene     
Positive 14 (93.3)   1 (6.7) 0.03(0.004-0.23),0.001 0.03(0.003-0.19),0.001 
Negative 33 (29.7) 78 (70.3) 1 1 
Key: COR = Crude Odds Ratio, AOR = Adjusted Odds Ratio, CI = Confidence Interval, PV = P-value, FHRH = 
Felege Hiwot Referral Hospital, DRH = Dessie Referral Hospital, DTH = Debre-Tabor Hospital 
 
 
Figure 1: Proportion of S. aureus and MRSA isolates by specimen type among HIV-infected children in 
Amhara National Regional State 
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Discussion 
In the current study, a prevalence of MRSA 
colonization was 37.3%, as computed from counts of 
MRSA at any one of the specimens collected from each 
patient. This finding was higher than the previous 
studies conducted in Jimma, Ethiopia (18.8%) (21) and 
Brazil (2.3%) (22). The probable reason for the high 
prevalence of MRSA in this study might be the better 
sensitivity and specificity of SCC mecA gen detection 
compared to phenotypic determination of MRSA. A 
higher isolation rate of MRSA (14%-29%) has also 
been reported in other African countries in which HIV 
comorbidity is common (18). Children with HIV 
represent a unique group for the acquisition of 
antimicrobial-resistant infections due to their frequent 
encounters with the health care system, need for 
empiric antimicrobials, and immune dysfunction. 
Moreover, a high isolation rate of MRSA (42.8%) was 
reported among health workers in Jimma, which needs 
greater attention on the prevention and control of 
nosocomial infections (23). A similar study conducted 
in Cape Town showed that, among HIV-positive 
children, approximately 77% were MRSA in which the 
colonization was associated with a greater degree of 
immune suppression (24). 
 
Among the three samples taken from the participants, 
the rate of MRSA detection was highest among 
samples collected from the perineum (59.5%). This 
might be due to the presence of mobile genetic element 
called staphylococcal cassette chromosome that 
encodes penicillin-binding proteins which is mostly 
acquired from S.  aureus population and/or 
gastrointestinal micro biota (25). 
 
The Panton–Valentine leukocidin (PVL) gene is 
produced from the genetic material of 
a bacteriophage that infects S. aureus, making it more 
virulent. In this study, 15 PVL-positive S. aureus 
strains (11.9%) were found in the carriage group (n = 
126). However, a higher prevalence of PVL (38.9%) 
was found in S. aureus strains causing abscesses and 
arthritis (26). Nearly all CA-MRSA strains appear to 
have the PVL gene, which has served as a genetic 
marker for identifying CA-MRSA. From our findings, 
the majority of MRSA colonizations were PVL gene 
negative. Since all of the participants were ambulatory, 
those colonized by the MRSA could easily transmit the 
pathogenic bacteria to other members of the 
community. Most of the time, types I to III 
SCCmec are large elements that typically contain 
additional resistance genes and are characteristically 
isolated from hospital-acquired MRSA (HA-MRSA) 
strains. Conversely, CA-MRSA is associated with 
types IV and V, which are smaller and lack resistance 
genes other than mecA (27,28). 
 
From multivariate analysis, most of the variables were 
not statistically significant. This may be due to the 
small sample size and the consequent lack of power to 
identify such associations, which was a limitation of 
this study. However, the study sites (P = 0.04) and PVL 
gene (P = 0.001) have a significant association with 
MRSA colonization. Another limitation of this study 
was the inability to address the lineage of the MRSA 
strain and lack of HIV viral load results. 
 
Conclusions:  
From this study, we found a high prevalence of 
pathogenic MRSA strains among HIV positive 
pediatric patients in the study area. The majority of 
MRSA types were HA-MRSA. Therefore, strict 
hygienic approaches by all healthcare workers in 
hospitals should be implemented to reduce the chance 
of HA-MRSA infections. Furthermore, a large-scale 
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